Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CRISPR-based diagnostics for ESKAPE drug-resistant bacteria: From proof-of-concept to point-of-care.

Talanta·2026
Same author

Dietary yacon concentrate reshapes microbial-metabolite crosstalk to inhibit colorectal cancer.

NPJ science of food·2026
Same author

Coal dust particles induce anxiety-like behaviors in the mice through lung-brain crosstalk.

Ecotoxicology and environmental safety·2026
Same author

Xylitol ameliorates ASD-like behavior in <i>Chd8</i><sup>+/-</sup> mice <i>via</i> modulations of the gut microbiome, neurotransmitters, and dendritic spine morphology.

Food & function·2026
Same author

Synergistic effects of <i>Bifidobacterium animalis subsp. lactis</i> Ca360 and zinc sulfate on zinc transport, oxidative stress, and intestinal inflammation in zinc-deficient mice.

Frontiers in nutrition·2026
Same author

A Synbiotic of Lacto-<i>N</i>-tetraose and <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> MN-Gup Attenuates High-Fat Diet-Induced Obesity by Modulating Metabolism and Gut Microbiota in Mice.

Nutrients·2026

Related Experiment Video

Updated: Aug 7, 2025

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.0K

Recent progress in cancer cell membrane-based nanoparticles for biomedical applications.

Qixiong Lin1, Yueyou Peng2, Yanyan Wen3

  • 1The Ninth Clinical Medical School of Shanxi Medical University, Taiyuan, Shanxi 030009, China.

Beilstein Journal of Nanotechnology
|March 10, 2023
PubMed
Summary

Biomimetic cancer cell membrane nanotechnology offers a novel approach to cancer treatment by improving drug delivery and targeting. These nanoparticles enhance therapeutic efficacy and diagnostic sensitivity while minimizing side effects for personalized medicine.

Keywords:
cancer cell biomimeticsnanoparticlesprecision medicinetargeted therapytheranostic nanomedicine

More Related Videos

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.0K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

15.9K

Related Experiment Videos

Last Updated: Aug 7, 2025

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.0K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.0K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

15.9K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Existing cancer therapies face limitations due to immune clearance, poor targeting, toxic side effects, and variable patient responses.
  • Biomedicine seeks innovative strategies to overcome these challenges in cancer treatment.

Purpose of the Study:

  • To review the properties and functions of cancer cell membranes in biomimetic nanotechnology.
  • To explore the therapeutic and diagnostic potential of cancer cell membrane-encapsulated nanoparticles.
  • To discuss the clinical translation prospects and challenges of this approach.

Main Methods:

  • Review of existing literature on cancer cell membrane biomimetics and nanotechnology.
  • Analysis of nanoparticle properties, including homotypic targeting, prolonged circulation, immune modulation, and barrier penetration.
  • Evaluation of applications in various diseases, including solid tumors, hematological malignancies, immune disorders, and cardiovascular diseases.

Main Results:

  • Cancer cell membrane-encapsulated nanoparticles demonstrate enhanced therapeutic capabilities and improved diagnostic sensitivity and specificity.
  • These nanoparticles exhibit beneficial effects such as homotypic targeting, extended drug circulation, immune system regulation, and enhanced biological barrier penetration.
  • Combination with current diagnostic and therapeutic methods improves effectiveness for individualized treatments.

Conclusions:

  • Biomimetic cancer cell membrane nanotechnology presents a promising strategy for overcoming limitations in current cancer therapies.
  • This approach offers potential for improved efficacy and reduced toxicity across diverse diseases, paving the way for personalized medicine.
  • Further research and development are needed to address clinical translation challenges and fully realize the potential of this technology.